Associations between serum amyloid A, interleukin‐6, and COVID‐19: A cross‐sectional study

Abstract

Serum amyloid A and IL-6 could be used as addition parameters to helping the distinguish of patients with COVID-19 from healthy people, and can provide potential basis for separating patients with nonsevere and severe clinical signs.